Clifton Huang
Pediatric Gastroenterology · Fort Worth, TXNPI 1184859175
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. AbbVie accounts for 83.8% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2020 at $6,453 and has fallen 72.2% since, to $1,795 in 2025. Among pediatric gastroenterology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $390.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$14K
- Boston Scientific$2K
- Mauna Kea Technologies, Inc.$212
- Olympus America Inc.$172
- Celltrion USA Inc.$146
- Johnson & Johnson$127
- plus $497 from 7 others
Across 32 payments — averaging $15,028 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$337K
- Bristol Myers Squibb$144K
- E.r. Squibb & Sons, L.L.C.$482
What the payments were for
- Consulting fees$2,85017%
- Speaking & faculty fees$8,97553%
- Travel & lodging$2,92817%
- Food & beverage$2,05912%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $14,080 |
| Boston Scientific | 11 | $1,579 |
| Mauna Kea Technologies, Inc. | 2 | $212 |
| Olympus America Inc. | 2 | $172 |
| Celltrion USA Inc. | 1 | $146 |
| Johnson & Johnson | 1 | $127 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $121 |
| Mirum Pharmaceuticals, Inc. | 1 | $118 |
| Cook Medical LLC | 1 | $38 |
| Pfizer | 2 | $34 |
| Boehringer Ingelheim | 1 | $33 |
| AstraZeneca | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Humira$7,077
- Apollo ESG NXT System$972
- EXALT Model D$232
- GENERAL - METAL STENTS - G.I.$148
- ZYMFENTRA$146
- Tremfya$127
- DUPIXENT$122
- GATTEX$121
- Livmarli$118
How this compares
$16,812 in reported general payments places this provider in the 90th percentile of 159 pediatric gastroenterology providers in Texas.
Other pediatric gastroenterology in Fort Worth
- Bankole OsuntokunFort Worth$2K
- Sherief MansiFort Worth$1K
- Naveen MittalDallas$182K
- Wenly RuanHouston$155K
- Amal AqulDallas$99K
- Stephanie AbramsHouston$94K
- Charina RamirezDallas$60K
- Ruben QuirosHouston$32K
- Daniel LeungHouston$31K
- Meghana SatheDallas$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.